Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration-Reference-Cited by-同舟云学术

Assessing the possible association of anti-TNF use with new malignancies: A neglected methodological consideration

Published:2018-06-19 Issue:8 Volume:27 Page:894-901
ISSN:1053-8569
Container-title:Pharmacoepidemiology and Drug Safety
language:en
Short-container-title:Pharmacoepidemiol Drug Saf

Author:

Ozguler Yesim¹^ORCID,Yazici Yusuf²,Hatemi Gulen¹,Tascilar Koray³,Yazici Hasan⁴

Affiliation:

1. Division of Rheumatology, Department of Internal Medicine, Cerrahpasa Medical Faculty; Istanbul University; Istanbul Turkey

2. New York University School of Medicine; New York NY USA

3. Okmeydani Research and Training Hospital; Istanbul Turkey

4. Academic Hospital; Istanbul Turkey

Publisher

Wiley

Subject

Pharmacology (medical),Epidemiology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/pds.4579/fullpdf

Reference45 articles.

1. Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk;Lebrec;Curr Med Res Opin,2015

2. Recommendations in the American College of Rheumatology Guideline for the treatment of rheumatoid arthritis related to the use of biologic agents in patients with a history of Cancer need reconsideration: comment on the article by Singh et al;Yazici;Arthritis Rheumatol,2016

3. Ozguler YYY Hatemi G Yazici H Assessing the possible association of anti-TNF use with new neoplasms: an important methodological consideration [abstract] 2015

4. Howlader N NA Krapcho M SEER Cancer Statistics Review http://seer.cancer.gov/csr/1975_2012/

5. Second malignant neoplasms: assessment and strategies for risk reduction;Wood;J Clin Oncol,2012

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of cancer after long-term therapy of autoimmune disorders with glucocorticoids or DMARDs—a controversial issue;memo - Magazine of European Medical Oncology;2019-07-12